In the early 1980s, Mr. Shen Jiaqiu, the former chairman of Ziguang Guhan Group Company, made unremitting efforts for more than ten years to develop and refine the "Guhan Health Care Essence" product, which was well-known throughout the country for 20 consecutive years, and developed a small factory that was on the verge of bankruptcy into the first listed company in Hunan with a production and sales of over 100 million yuan, and improved its quality with taste (history and culture). The company was approved by China Securities Regulatory Commission on February 25th, 2000 1995, 198, and listed on Shenzhen Stock Exchange on September 29th, 2000.
Ziguang Guhan Group is the largest biochemical pharmaceutical enterprise of Chinese and western medicines in Hunan, one of the top 50 key enterprises in Chinese patent medicine industry, and one of the largest infusion production enterprises in China. It is committed to building the first brand of health experts in China, the top three brands of biopharmaceuticals in China, and the first-class brand of western medicine preparations in China. The company is mainly engaged in the research and development of China traditional Chinese medicine secret recipes, prescriptions, western medicine preparations and biological products, and has 63 varieties of Chinese patent medicines, health products, Lomefloxacin hydrochloride injection, clindamycin phosphate injection and infusion, including Guhanshengjing (oral liquid, tablets), Youlikang, Xinnaobaotai oral liquid, Guhanbaochun suppository, Qingshu Jiedu granules and Xihan ancient wine.
Ziguang Guhan Group Co., Ltd. was approved by China Securities Regulatory Commission 1995 198 on February 25th and listed on Shenzhen Stock Exchange on June 1996 19. On September 29th, 2000, it was renamed Guhan Ziguang Biopharmaceutical Co., Ltd., and on July 6th, 2007, it was renamed Ziguang Guhan Group Co., Ltd. again (hereinafter referred to as "the Company"). Over the years, the company's total share capital was RMB 203,028,425.00 by means of bonus shares, capitalization of reserve funds and rights issue. In August 2006, the relevant shareholders' meeting of the company reviewed and approved the share-trading reform plan of Ziguang Guhan Biopharmaceutical Co., Ltd., and implemented the share-trading reform according to this plan. Non-tradable shareholders of the Company shall make consideration arrangements for all tradable shareholders registered on the registration date of equity change during the implementation of this scheme by paying shares. For every 65,438+00 tradable shares held by shareholders, 3.5 shares were obtained, and the total number of shares paid for was 22,243,900 shares. By the end of 2007, the company's total share capital was 203,028,425 shares, of which 59,206,654,38+0,000 shares were tradable, accounting for 29.654,38+06% of the total share capital; Unlimited tradable shares143,822,300 shares, accounting for 7 1.84% of the total share capital.
Ziguang Guhan Group Co., Ltd. has a total share capital of 203 million shares, total assets of 662 million yuan and net assets of 272 million yuan. The company has subsidiaries such as Ziguang Guhan Group Hengyang Traditional Chinese Medicine Pharmaceutical Co., Ltd., Ziguang Guhan Group Hengyang Pharmaceutical Co., Ltd. and Hunan Ziguang Guhan Nanyue Pharmaceutical Co., Ltd., and is committed to researching and developing traditional Chinese medicine secrets, prescriptions, western medicine preparations and biological products. There are 63 varieties of Chinese patent medicines and health care products in eight dosage forms, including Guhanshengjing (oral liquid and tablet), Xinnaobaotai oral liquid, Guhanbaochun suppository, Qingshu Jiedu granule and Liuwei Dihuang pill, and 47 varieties of western medicine preparations/kloc-0 in seven dosage forms, including Lomefloxacin hydrochloride injection, clindamycin phosphate injection and infusion, as well as 40 biological preparations such as human albumin injection and human immunoglobulin injection. At present, it is the largest comprehensive pharmaceutical enterprise of Chinese and western medicine biological products in Hunan Province and even the whole country, and its products are exported at home and abroad. High-tech enterprises in Hunan Province. The company integrates with Tsinghua University to form a pattern of complementary advantages and strong alliance. With the continuous injection of Tsinghua University's advanced management concepts, core technologies and high-quality assets, the company is facing brand-new development opportunities.
Ziguang Guhan Group Co., Ltd. will adhere to the essence of China traditional culture, practice the concept of filial piety culture, aim at the enterprise positioning goal of high-tech, specialization, internationalization and popularization, build the first brand of health experts in China, realize the perfect combination of traditional medicine and modern medicine, and strive to become a giant of national medicine industry.